VITAMIN A AND D

VITAMIN A AND D was reported 221 times

VITAMIN A AND D is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INCREASED ANTEROPOSTERIOR CHEST DIAMETER 1 0.1250
1 MONONUCLEAR CELL COUNT INCREASED 1 0.0909
2 PRURITUS ANI 1 0.0169
3 CITROBACTER TEST POSITIVE 1 0.0152
4 RECTAL CANCER RECURRENT 1 0.0118
5 OLIGODENDROGLIOMA 1 0.0083
6 HYPERBARIC OXYGEN THERAPY 1 0.0060
7 MALIGNANT NEOPLASM OF SPINAL CORD 1 0.0055
8 PYELONEPHRITIS CHRONIC 1 0.0053
9 CD8 LYMPHOCYTES DECREASED 1 0.0050
10 PORTAL FIBROSIS 1 0.0047
11 PROTEUS TEST POSITIVE 1 0.0045
12 BIOPSY LIVER ABNORMAL 1 0.0033
13 GENITAL PRURITUS FEMALE 1 0.0031
14 DISTAL INTESTINAL OBSTRUCTION SYNDROME 1 0.0030
15 HYPOCHROMIC ANAEMIA 3 0.0030
16 CUBITAL TUNNEL SYNDROME 1 0.0029
17 FAT EMBOLISM 1 0.0028
18 SKIN TURGOR DECREASED 1 0.0026
19 HEMIPARAESTHESIA 1 0.0026
20 EXPOSURE VIA EYE CONTACT 1 0.0024
21 COLONOSCOPY ABNORMAL 1 0.0023
22 BONE DEBRIDEMENT 1 0.0021
23 CHRONIC MYELOID LEUKAEMIA RECURRENT 1 0.0018
24 LUNG INFECTION PSEUDOMONAL 1 0.0018
25 VESTIBULAR DISORDER 2 0.0016
26 BLOOD CORTISOL DECREASED 1 0.0016
27 ABDOMINAL WALL ABSCESS 1 0.0015
28 MACULAR FIBROSIS 1 0.0015
29 T-LYMPHOCYTE COUNT DECREASED 1 0.0015
30 SPUTUM INCREASED 3 0.0014
31 NODAL RHYTHM 2 0.0014
32 CHOLANGITIS ACUTE 1 0.0013
33 TRACHEITIS 1 0.0013
34 ADRENAL SUPPRESSION 1 0.0012
35 OVARIAN CANCER METASTATIC 1 0.0012
36 SPINAL CORD NEOPLASM 1 0.0011
37 ANAEMIA OF CHRONIC DISEASE 1 0.0011
38 ACTINOMYCOSIS 1 0.0010
39 EYELID PAIN 2 0.0010
40 GALLBLADDER ENLARGEMENT 1 0.0009
41 DRUG EXPOSURE VIA BREAST MILK 1 0.0009
42 FACIAL SPASM 1 0.0009
43 PRIAPISM 3 0.0009
44 APPLICATION SITE EROSION 1 0.0008
45 ACROCHORDON 1 0.0008
46 B-LYMPHOCYTE COUNT DECREASED 1 0.0007
47 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 4 0.0007
48 RHONCHI 1 0.0007
49 PRECANCEROUS CELLS PRESENT 1 0.0007
50 SINUS ARREST 1 0.0006
51 OPTIC NERVE DISORDER 1 0.0006
52 BILIARY DYSKINESIA 1 0.0006
53 TREATMENT DELAYED 1 0.0006
54 OTORRHOEA 1 0.0006
55 PANCREATIC FAILURE 1 0.0006
56 KYPHOSIS 1 0.0006
57 HISTOPLASMOSIS 1 0.0006
58 FIBRIN D DIMER INCREASED 2 0.0006
59 DRUG WITHDRAWAL CONVULSIONS 1 0.0006
60 PARAPARESIS 1 0.0006
61 ESSENTIAL HYPERTENSION 1 0.0005
62 SINUS NODE DYSFUNCTION 1 0.0005
63 BLOOD IRON INCREASED 1 0.0005
64 PERONEAL NERVE PALSY 3 0.0005
65 HYPERCOAGULATION 1 0.0005
66 RENAL HAEMORRHAGE 1 0.0005
67 CHOLANGITIS SCLEROSING 1 0.0005
68 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
69 CD4 LYMPHOCYTES DECREASED 1 0.0005
70 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
71 PULMONARY FUNCTION TEST DECREASED 2 0.0005
72 GASTRIC POLYPS 1 0.0004
73 ABNORMAL LOSS OF WEIGHT 3 0.0004
74 NEUROLOGICAL DECOMPENSATION 1 0.0004
75 SINUS OPERATION 1 0.0004
76 FOOT OPERATION 2 0.0004
77 EYELID IRRITATION 1 0.0004
78 VASODILATATION 1 0.0004
79 ENDODONTIC PROCEDURE 1 0.0004
80 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
81 SERUM FERRITIN INCREASED 2 0.0004
82 ULCERATIVE KERATITIS 1 0.0004
83 CREPITATIONS 1 0.0003
84 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
85 RECTAL CANCER 1 0.0003
86 PORTAL HYPERTENSION 1 0.0003
87 INFUSION SITE PRURITUS 1 0.0003
88 FACET JOINT SYNDROME 1 0.0003
89 NEOPLASM RECURRENCE 1 0.0003
90 HEPATIC FIBROSIS 1 0.0003
91 DIFFICULTY IN WALKING 1 0.0003
92 THROMBOPHLEBITIS 1 0.0003
93 APPENDICECTOMY 1 0.0003
94 NEUTROPENIC SEPSIS 2 0.0003
95 MONOCYTE COUNT INCREASED 1 0.0003
96 DENTAL CARIES 3 0.0003
97 WOUND HAEMORRHAGE 1 0.0003
98 THYROID MASS 1 0.0003
99 PRODUCT USE COMPLAINT 4 0.0003
100 SKIN PAPILLOMA 1 0.0002
101 STENT PLACEMENT 2 0.0002
102 PERIPHERAL VENOUS DISEASE 1 0.0002
103 PERIPHERAL ISCHAEMIA 1 0.0002
104 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
105 SECOND PRIMARY MALIGNANCY 2 0.0002
106 ONYCHOMADESIS 1 0.0002
107 MONOPLEGIA 1 0.0002
108 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
109 MELANOCYTIC NAEVUS 1 0.0002
110 ONYCHOMYCOSIS 1 0.0002
111 ABDOMINAL ABSCESS 1 0.0002
112 RHEUMATIC FEVER 1 0.0002
113 EAR DISORDER 1 0.0002
114 ISCHAEMIA 1 0.0002
115 HYPOVOLAEMIC SHOCK 1 0.0002
116 FINGER DEFORMITY 1 0.0002
117 STAPHYLOCOCCAL SEPSIS 1 0.0002
118 KLEBSIELLA INFECTION 1 0.0002
119 TOE AMPUTATION 1 0.0002
120 CACHEXIA 1 0.0002
121 SKIN NECROSIS 1 0.0002
122 MALABSORPTION 1 0.0002
123 FOOD POISONING 1 0.0002
124 GINGIVITIS 1 0.0002
125 STRESS FRACTURE 1 0.0002
126 NORMAL NEWBORN 1 0.0002
127 MACULAR OEDEMA 1 0.0002
128 PRODUCT LEAKAGE 1 0.0002
129 CARDIAC VALVE DISEASE 1 0.0002
130 EXERCISE TOLERANCE DECREASED 1 0.0002
131 RALES 1 0.0002
132 PRODUCT LABEL CONFUSION 1 0.0002
133 DECREASED INTEREST 1 0.0002
134 DRUG ABUSER 1 0.0002
135 BLEPHAROSPASM 1 0.0002
136 PHOTOPSIA 1 0.0002
137 SCREAMING 1 0.0002
138 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
139 POOR QUALITY DRUG ADMINISTERED 1 0.0002
140 BREAST CANCER STAGE III 1 0.0002
141 APPLICATION SITE VESICLES 1 0.0002
142 PLATELET COUNT INCREASED 2 0.0002
143 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
144 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
145 BRONCHIECTASIS 1 0.0001
146 PRODUCT LABEL ISSUE 1 0.0001
147 CORONARY ARTERY OCCLUSION 2 0.0001
148 LYMPHOEDEMA 1 0.0001
149 LARGE INTESTINE POLYP 1 0.0001
150 AUTOIMMUNE HEPATITIS 1 0.0001
151 APHONIA 2 0.0001
152 SEASONAL ALLERGY 2 0.0001
153 DIVERTICULUM 1 0.0001
154 RED BLOOD CELL COUNT DECREASED 4 0.0001
155 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
156 VISUAL FIELD DEFECT 1 0.0001
157 APPLICATION SITE PAIN 3 0.0001
158 DUODENAL ULCER PERFORATION 1 0.0001
159 MUSCULOSKELETAL PAIN 7 0.0001
160 HYDRONEPHROSIS 1 0.0001
161 RENAL FAILURE CHRONIC 1 0.0001
162 HAEMOLYSIS 1 0.0001
163 MUSCULOSKELETAL CHEST PAIN 2 0.0001
164 ACUTE MYELOID LEUKAEMIA 2 0.0001
165 AFFECTIVE DISORDER 1 0.0001
166 DRUG SCREEN POSITIVE 1 0.0001
167 RESPIRATORY TRACT CONGESTION 2 0.0001
168 OBESITY 2 0.0001
169 SENSORY LOSS 1 0.0001
170 DECUBITUS ULCER 1 0.0001
171 MENSTRUAL DISORDER 1 0.0001
172 MUSCLE INJURY 1 0.0001
173 LIVE BIRTH 1 0.0001
174 PRODUCT CONTAINER ISSUE 1 0.0001
175 BLOOD MAGNESIUM DECREASED 1 0.0001
176 MUSCLE STRAIN 1 0.0001
177 PYELONEPHRITIS 1 0.0001
178 NAIL DISORDER 1 0.0001
179 GRIP STRENGTH DECREASED 1 0.0001
180 COLD SWEAT 2 0.0001
181 HAEMOLYTIC ANAEMIA 1 0.0001
182 HAEMARTHROSIS 1 0.0001
183 ANAL INCONTINENCE 1 0.0001
184 OROPHARYNGEAL DISCOMFORT 1 0.0001
185 LIP DRY 1 0.0001
186 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
187 RETINAL DETACHMENT 1 0.0001
188 LACERATION 1 0.0001
189 FOOT FRACTURE 2 0.0001
190 SPUTUM DISCOLOURED 1 0.0001
191 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
192 POST PROCEDURAL COMPLICATION 2 0.0001
193 HYPERCHOLESTEROLAEMIA 1 0.0001
194 VITAMIN D DEFICIENCY 1 0.0001
195 SKIN FISSURES 2 0.0001
196 COELIAC DISEASE 1 0.0001
197 HEPATOMEGALY 1 0.0001
198 VITREOUS FLOATERS 1 0.0001
199 HOSPICE CARE 1 0.0001
200 LIGAMENT SPRAIN 1 0.0001
201 BLADDER DISORDER 1 0.0001
202 HYPOTONIA 1 0.0001
203 OVARIAN CYST 1 0.0001
204 BLOOD POTASSIUM DECREASED 3 0.0001
205 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
206 EYELID PTOSIS 1 0.0001
207 TOOTH ABSCESS 1 0.0001
208 SLUGGISHNESS 1 0.0001
209 NEUTROPHIL COUNT INCREASED 1 0.0001
210 HELICOBACTER INFECTION 1 0.0001
211 TEMPERATURE INTOLERANCE 1 0.0001
212 HYPERBILIRUBINAEMIA 1 0.0001
213 VENTRICULAR EXTRASYSTOLES 1 0.0001
214 EYE DISCHARGE 1 0.0001
215 FOLLICULITIS 1 0.0001
216 INCONTINENCE 1 0.0001
217 JOINT DISLOCATION 1 0.0001
218 NIGHT SWEATS 3 0.0001
219 FAECES DISCOLOURED 2 0.0001
220 BACK INJURY 1 0.0001
221 WOUND INFECTION 1 0.0001
222 GASTROINTESTINAL PAIN 1 0.0001
223 OCULAR DISCOMFORT 1 0.0001
224 EYE PAIN 5 0.0001
225 STATUS EPILEPTICUS 1 0.0001
226 SPLENOMEGALY 1 0.0001
227 SPINAL PAIN 1 0.0001
228 WHEEZING 5 0.0001
229 HYPERLIPIDAEMIA 1 0.0001
230 HEPATITIS C 1 0.0001
231 BURSITIS 1 0.0001
232 NO THERAPEUTIC RESPONSE 1 0.0001
233 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
234 ILEUS 1 0.0001
235 APPLICATION SITE IRRITATION 1 0.0001
236 TOOTH EXTRACTION 1 0.0001
237 PEMPHIGUS 1 0.0001
238 COLITIS 3 0.0001
239 ANOREXIA 1 0.0001
240 SPEECH DISORDER 4 0.0001
241 HAND DEFORMITY 1 0.0001
242 ADVERSE REACTION 1 0.0001
243 JOINT RANGE OF MOTION DECREASED 1 0.0001
244 ORAL DISCOMFORT 1 0.0001
245 BLOOD TEST ABNORMAL 1 0.0001
246 DEVICE OCCLUSION 1 0.0001
247 HEPATOCELLULAR INJURY 1 0.0001
248 MUSCULAR WEAKNESS 8 0.0001
249 SUBDURAL HAEMATOMA 1 0.0001
250 HYPERSOMNIA 2 0.0001
251 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
252 HAEMOGLOBIN DECREASED 7 0.0001
253 SKIN HAEMORRHAGE 1 0.0001
254 HAEMORRHAGE INTRACRANIAL 1 0.0001
255 RESPIRATORY DISORDER 2 0.0001
256 HYPOAESTHESIA ORAL 1 0.0001
257 FEELING HOT 4 0.0001
258 DRUG-INDUCED LIVER INJURY 2 0.0001
259 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
260 SENSORY DISTURBANCE 1 0.0001
261 MUSCLE TIGHTNESS 1 0.0001
262 INFUSION RELATED REACTION 4 0.0001
263 PERICARDITIS 1 0.0001
264 DELIRIUM 2 0.0001
265 SYRINGE ISSUE 1 0.0001
266 BRADYCARDIA 3 0.0001
267 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
268 GALLBLADDER DISORDER 1 0.0001
269 SYNOVITIS 1 0.0001
270 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
271 TOOTHACHE 1 0.0001
272 OSTEOMYELITIS 1 0.0001
273 C-REACTIVE PROTEIN INCREASED 2 0.0001
274 BONE DISORDER 1 0.0001
275 DYSURIA 2 0.0001
276 BLOOD GLUCOSE ABNORMAL 1 0.0001
277 BRONCHITIS 4 0.0001
278 EYE SWELLING 2 0.0001
279 NECK PAIN 3 0.0001
280 MIDDLE INSOMNIA 1 0.0001
281 HEPATIC CIRRHOSIS 1 0.0001
282 PHOTOPHOBIA 1 0.0001
283 INTESTINAL OBSTRUCTION 2 0.0001
284 HYPOCALCAEMIA 1 0.0001
285 FRACTURE 1 0.0001
286 PULMONARY EMBOLISM 5 0.0001
287 SLEEP APNOEA SYNDROME 1 0.0001
288 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
289 PRODUCT SUBSTITUTION ISSUE 3 0.0001
290 CHOLESTASIS 1 0.0001
291 HERNIA 1 0.0001
292 VISION BLURRED 7 0.0001
293 SINUS DISORDER 1 0.0001
294 ABNORMAL BEHAVIOUR 2 0.0001
295 DISORIENTATION 2 0.0001
296 FULL BLOOD COUNT DECREASED 1 0.0000
297 PRODUCT PHYSICAL ISSUE 1 0.0000
298 PRODUCT ADMINISTRATION ERROR 1 0.0000
299 TASTE DISORDER 1 0.0000
300 PSORIATIC ARTHROPATHY 2 0.0000
301 NEUTROPHIL COUNT DECREASED 2 0.0000
302 INSOMNIA 13 0.0000
303 TOOTH LOSS 1 0.0000
304 POLLAKIURIA 2 0.0000
305 INTENTIONAL DRUG MISUSE 1 0.0000
306 DERMATITIS 1 0.0000
307 JOINT INJURY 1 0.0000
308 IRRITABLE BOWEL SYNDROME 1 0.0000
309 LIVER FUNCTION TEST INCREASED 1 0.0000
310 POOR QUALITY SLEEP 1 0.0000
311 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
312 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
313 MUSCULOSKELETAL STIFFNESS 4 0.0000
314 MELAENA 1 0.0000
315 LIVER DISORDER 2 0.0000
316 DEHYDRATION 6 0.0000
317 TRANSAMINASES INCREASED 1 0.0000
318 GLOSSODYNIA 1 0.0000
319 THROAT IRRITATION 2 0.0000
320 PANCREATITIS ACUTE 1 0.0000
321 CHROMATURIA 1 0.0000
322 APPLICATION SITE PRURITUS 1 0.0000
323 PRODUCT AVAILABILITY ISSUE 1 0.0000
324 MEMORY IMPAIRMENT 6 0.0000
325 INJECTION SITE REACTION 3 0.0000
326 MUSCLE TWITCHING 1 0.0000
327 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
328 INJURY 3 0.0000
329 PRODUCTIVE COUGH 2 0.0000
330 MOBILITY DECREASED 3 0.0000
331 FIBROMYALGIA 1 0.0000
332 PRESYNCOPE 1 0.0000
333 LIVER INJURY 1 0.0000
334 DYSPEPSIA 4 0.0000
335 ABASIA 1 0.0000
336 AGEUSIA 1 0.0000
337 PNEUMONIA ASPIRATION 1 0.0000
338 CELLULITIS 2 0.0000
339 FLUSHING 4 0.0000
340 HEPATITIS 1 0.0000
341 SINUSITIS 4 0.0000
342 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
343 RASH GENERALISED 1 0.0000
344 HAEMATOMA 1 0.0000
345 ABDOMINAL DISTENSION 4 0.0000
346 DEAFNESS 1 0.0000
347 GASTRITIS 1 0.0000
348 PAIN OF SKIN 1 0.0000
349 DISTURBANCE IN ATTENTION 2 0.0000
350 FREQUENT BOWEL MOVEMENTS 1 0.0000
351 BLOOD BILIRUBIN INCREASED 1 0.0000
352 HAEMATOCHEZIA 2 0.0000
353 DIVERTICULITIS 1 0.0000
354 PROCEDURAL PAIN 1 0.0000
355 ARTHROPATHY 2 0.0000
356 HAEMOPTYSIS 1 0.0000
357 URTICARIA 6 0.0000
358 PANCYTOPENIA 2 0.0000
359 WOUND 1 0.0000
360 BLISTER 2 0.0000
361 PAIN IN JAW 1 0.0000
362 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
363 ANGINA PECTORIS 1 0.0000
364 BALANCE DISORDER 3 0.0000
365 NEEDLE ISSUE 1 0.0000
366 DYSSTASIA 1 0.0000
367 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
368 HYPOAESTHESIA 5 0.0000
369 HEPATIC FAILURE 1 0.0000
370 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
371 EPILEPSY 1 0.0000
372 INJECTION SITE RASH 1 0.0000
373 PERIPHERAL SWELLING 5 0.0000
374 CHEST PAIN 6 0.0000
375 FEMUR FRACTURE 1 0.0000
376 NERVOUS SYSTEM DISORDER 1 0.0000
377 PRODUCT USE ISSUE 6 0.0000
378 BONE DENSITY DECREASED 1 0.0000
379 PYREXIA 11 0.0000
380 ANAEMIA 6 0.0000
381 MIGRAINE 3 0.0000
382 CYSTITIS 1 0.0000
383 MOOD SWINGS 1 0.0000
384 CONTUSION 3 0.0000
385 MOVEMENT DISORDER 1 0.0000
386 HIP FRACTURE 1 0.0000
387 DEPRESSION 7 0.0000
388 IMPAIRED HEALING 1 0.0000
389 OSTEONECROSIS 1 0.0000
390 DECREASED APPETITE 7 0.0000
391 TREMOR 5 0.0000
392 VISUAL ACUITY REDUCED 1 0.0000
393 BLOOD PRESSURE DECREASED 2 0.0000
394 ABDOMINAL PAIN 7 0.0000
395 EXPIRED PRODUCT ADMINISTERED 1 0.0000
396 VIRAL INFECTION 1 0.0000
397 FALL 10 0.0000
398 SYNCOPE 3 0.0000
399 URINARY RETENTION 1 0.0000
400 GAIT INABILITY 1 0.0000
401 TYPE 2 DIABETES MELLITUS 1 0.0000
402 HAEMATURIA 1 0.0000
403 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
404 GASTRIC DISORDER 1 0.0000
405 DEVICE USE ERROR 1 0.0000
406 NEOPLASM PROGRESSION 1 0.0000
407 DYSPNOEA 16 0.0000
408 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
409 PLATELET COUNT DECREASED 3 0.0000
410 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
411 CRYING 1 0.0000
412 UNDERDOSE 2 0.0000
413 MUSCLE SPASMS 5 0.0000
414 PAIN IN EXTREMITY 8 0.0000
415 INJECTION SITE MASS 1 0.0000
416 INFLUENZA 3 0.0000
417 SEPSIS 3 0.0000
418 DYSPNOEA EXERTIONAL 1 0.0000
419 ASTHMA 3 0.0000
420 HOSPITALISATION 4 0.0000
421 SEIZURE 3 0.0000
422 VOMITING 12 0.0000
423 ALOPECIA 5 0.0000
424 NAUSEA 20 0.0000
425 MALAISE 11 0.0000
426 WEIGHT DECREASED 7 0.0000
427 INJECTION SITE BRUISING 2 0.0000
428 JOINT SWELLING 3 0.0000
429 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
430 SOMNOLENCE 5 0.0000
431 DIARRHOEA 16 0.0000
432 CONFUSIONAL STATE 4 0.0000
433 PNEUMONIA 8 0.0000
434 DRY MOUTH 2 0.0000
435 OEDEMA PERIPHERAL 3 0.0000
436 DYSKINESIA 1 0.0000
437 CARDIAC ARREST 2 0.0000
438 VISUAL IMPAIRMENT 3 0.0000
439 INJECTION SITE ERYTHEMA 3 0.0000
440 DIZZINESS 12 0.0000
441 CARDIO-RESPIRATORY ARREST 1 0.0000
442 CEREBROVASCULAR ACCIDENT 4 0.0000
443 OSTEOARTHRITIS 1 0.0000
444 URINARY TRACT INFECTION 4 0.0000
445 HYPOACUSIS 1 0.0000
446 SEPTIC SHOCK 1 0.0000
447 DRUG WITHDRAWAL SYNDROME 2 0.0000
448 COLITIS ULCERATIVE 1 0.0000
449 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
450 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
451 NEUTROPENIA 3 0.0000
452 FATIGUE 17 0.0000
453 NEPHROLITHIASIS 1 0.0000
454 SKIN DISCOLOURATION 1 0.0000
455 BLOOD CHOLESTEROL INCREASED 1 0.0000
456 COGNITIVE DISORDER 1 0.0000
457 SWELLING 2 0.0000
458 OCULAR HYPERAEMIA 1 0.0000
459 DYSPHAGIA 2 0.0000
460 DISEASE RECURRENCE 1 0.0000
461 RASH ERYTHEMATOUS 1 0.0000
462 HYPOGLYCAEMIA 1 0.0000
463 ATRIAL FIBRILLATION 2 0.0000
464 LUNG DISORDER 1 0.0000
465 LEUKOPENIA 1 0.0000
466 HYPOTENSION 4 0.0000
467 INFLAMMATION 1 0.0000
468 HEADACHE 12 0.0000
469 PARAESTHESIA 3 0.0000
470 DEPRESSED MOOD 1 0.0000
471 DRUG INTERACTION 3 0.0000
472 HYPERTENSION 4 0.0000
473 ASTHENIA 7 0.0000
474 ABDOMINAL DISCOMFORT 3 0.0000
475 COUGH 5 0.0000
476 OXYGEN SATURATION DECREASED 1 0.0000
477 HYPONATRAEMIA 1 0.0000
478 MYALGIA 3 0.0000
479 RHEUMATOID ARTHRITIS 2 0.0000
480 CONVULSION 1 0.0000
481 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
482 BACK PAIN 4 0.0000
483 COVID-19 3 0.0000
484 DYSPHONIA 1 0.0000
485 PALPITATIONS 2 0.0000
486 BONE PAIN 1 0.0000
487 CHILLS 2 0.0000
488 NASAL CONGESTION 1 0.0000
489 PRODUCT DOSE OMISSION ISSUE 5 0.0000
490 DISEASE PROGRESSION 2 0.0000
491 CATARACT 1 0.0000
492 FEELING ABNORMAL 4 0.0000
493 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
494 STOMATITIS 1 0.0000
495 ILL-DEFINED DISORDER 1 0.0000
496 VERTIGO 1 0.0000
497 PAIN 10 0.0000
498 NASOPHARYNGITIS 3 0.0000
499 HYPERSENSITIVITY 3 0.0000
500 EXPOSURE DURING PREGNANCY 1 0.0000
501 LOSS OF CONSCIOUSNESS 2 0.0000
502 HYPERHIDROSIS 2 0.0000
503 DEEP VEIN THROMBOSIS 1 0.0000
504 BLOOD CREATININE INCREASED 1 0.0000
505 DRY SKIN 2 0.0000
506 PRODUCT QUALITY ISSUE 2 0.0000
507 HEPATIC ENZYME INCREASED 1 0.0000
508 ERYTHEMA 3 0.0000
509 ABDOMINAL PAIN UPPER 3 0.0000
510 BURNING SENSATION 1 0.0000
511 SLEEP DISORDER 1 0.0000
512 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
513 SKIN BURNING SENSATION 1 0.0000
514 RASH 6 0.0000
515 CONSTIPATION 3 0.0000
516 RESPIRATORY FAILURE 1 0.0000
517 EPISTAXIS 1 0.0000
518 HALLUCINATION 1 0.0000
519 HOT FLUSH 1 0.0000
520 DIABETES MELLITUS 1 0.0000
521 INJECTION SITE SWELLING 1 0.0000
522 PRURITUS 5 0.0000
523 INJECTION SITE HAEMORRHAGE 1 0.0000
524 CARDIAC FAILURE 1 0.0000
525 THROMBOSIS 1 0.0000
526 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
527 TREATMENT FAILURE 1 0.0000
528 ARTHRALGIA 5 0.0000
529 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
530 RENAL IMPAIRMENT 1 0.0000
531 SKIN EXFOLIATION 1 0.0000
532 MYOCARDIAL INFARCTION 2 0.0000
533 TACHYCARDIA 1 0.0000
534 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
535 GASTROINTESTINAL DISORDER 1 0.0000
536 DEVICE ISSUE 1 0.0000
537 ADVERSE DRUG REACTION 1 0.0000
538 ADVERSE EVENT 1 0.0000
539 OROPHARYNGEAL PAIN 1 0.0000
540 BREAST CANCER 1 0.0000
541 NEUROPATHY PERIPHERAL 1 0.0000
542 DRUG INTOLERANCE 1 0.0000
543 HEART RATE INCREASED 1 0.0000
544 CHEST DISCOMFORT 1 0.0000
545 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
546 HAEMORRHAGE 1 0.0000
547 OVERDOSE 2 0.0000
548 THROMBOCYTOPENIA 1 0.0000
549 WEIGHT INCREASED 2 0.0000
550 DRUG INEFFECTIVE 11 0.0000
551 DEATH 7 0.0000
552 OFF LABEL USE 7 0.0000
553 PSORIASIS 1 0.0000
554 RENAL FAILURE 1 0.0000
555 INFECTION 1 0.0000
556 CONDITION AGGRAVATED 2 0.0000
557 ACUTE KIDNEY INJURY 1 0.0000
558 DRUG DOSE OMISSION 1 0.0000
559 GAIT DISTURBANCE 1 0.0000
560 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
561 INCORRECT DOSE ADMINISTERED 1 0.0000
562 ANXIETY 1 0.0000
563 INJECTION SITE PAIN 1 0.0000